638 related articles for article (PubMed ID: 16540676)
21. Antimitotic effect of the retinoid 4-oxo-fenretinide through inhibition of tubulin polymerization: a novel mechanism of retinoid growth-inhibitory activity.
Appierto V; Tiberio P; Cavadini E; Casalini P; Cappelletti G; Formelli F
Mol Cancer Ther; 2009 Dec; 8(12):3360-8. PubMed ID: 19996280
[TBL] [Abstract][Full Text] [Related]
22. The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family.
Boya P; Morales MC; Gonzalez-Polo RA; Andreau K; Gourdier I; Perfettini JL; Larochette N; Deniaud A; Baran-Marszak F; Fagard R; Feuillard J; Asumendi A; Raphael M; Pau B; Brenner C; Kroemer G
Oncogene; 2003 Sep; 22(40):6220-30. PubMed ID: 13679861
[TBL] [Abstract][Full Text] [Related]
23. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
Yang YI; Kim JH; Lee KT; Choi JH
Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
[TBL] [Abstract][Full Text] [Related]
24. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
Xu H; Cheepala S; McCauley E; Coombes K; Xiao L; Fischer SM; Clifford JL
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):969-79. PubMed ID: 16467112
[TBL] [Abstract][Full Text] [Related]
25. 4-oxo-N-(4-hydroxyphenyl)retinamide: two independent ways to kill cancer cells.
Tiberio P; Cavadini E; Abolafio G; Formelli F; Appierto V
PLoS One; 2010 Oct; 5(10):e13362. PubMed ID: 20976277
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia-mediated fenretinide (4-HPR) resistance in childhood acute lymphoblastic leukemia cells.
Yang B; Fan L; Fang L; He Q
Cancer Chemother Pharmacol; 2006 Oct; 58(4):540-6. PubMed ID: 16520989
[TBL] [Abstract][Full Text] [Related]
27. Physalis angulata induced G2/M phase arrest in human breast cancer cells.
Hsieh WT; Huang KY; Lin HY; Chung JG
Food Chem Toxicol; 2006 Jul; 44(7):974-83. PubMed ID: 16427178
[TBL] [Abstract][Full Text] [Related]
28. Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model.
Qamar L; Davis R; Anwar A; Behbakht K
Gynecol Oncol; 2008 Sep; 110(3):425-31. PubMed ID: 18619662
[TBL] [Abstract][Full Text] [Related]
29. PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation.
Appierto V; Tiberio P; Villani MG; Cavadini E; Formelli F
Carcinogenesis; 2009 May; 30(5):824-31. PubMed ID: 19325135
[TBL] [Abstract][Full Text] [Related]
30. The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response.
Pagnan G; Di Paolo D; Carosio R; Pastorino F; Marimpietri D; Brignole C; Pezzolo A; Loi M; Galietta LJ; Piccardi F; Cilli M; Nico B; Ribatti D; Pistoia V; Ponzoni M
Clin Cancer Res; 2009 Feb; 15(4):1199-209. PubMed ID: 19228726
[TBL] [Abstract][Full Text] [Related]
31. Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells.
Appierto V; Villani MG; Cavadini E; Lotan R; Vinson C; Formelli F
Cell Death Differ; 2004 Mar; 11(3):270-9. PubMed ID: 14647238
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis resistance of MCF-7 breast carcinoma cells to ionizing radiation is independent of p53 and cell cycle control but caused by the lack of caspase-3 and a caffeine-inhibitable event.
Essmann F; Engels IH; Totzke G; Schulze-Osthoff K; Jänicke RU
Cancer Res; 2004 Oct; 64(19):7065-72. PubMed ID: 15466201
[TBL] [Abstract][Full Text] [Related]
33. [Induction of G2 /M phase arrest and apoptosis of MCF-7 cells by novel benzofuran lignan via suppressing cell cycle proteins].
Yang H; Cai YC; Pang JY; Li YQ; Zeng ZL; Xu ZL; Xian LJ
Yao Xue Xue Bao; 2008 Feb; 43(2):138-44. PubMed ID: 18507339
[TBL] [Abstract][Full Text] [Related]
34. Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma.
Lovat PE; Ranalli M; Annichiarrico-Petruzzelli M; Bernassola F; Piacentini M; Malcolm AJ; Pearson AD; Melino G; Redfern CP
Exp Cell Res; 2000 Oct; 260(1):50-60. PubMed ID: 11010810
[TBL] [Abstract][Full Text] [Related]
35. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.
Maurer BJ; Metelitsa LS; Seeger RC; Cabot MC; Reynolds CP
J Natl Cancer Inst; 1999 Jul; 91(13):1138-46. PubMed ID: 10393722
[TBL] [Abstract][Full Text] [Related]
36. N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cells.
Simeone AM; Deng CX; Kelloff GJ; Steele VE; Johnson MM; Tari AM
Carcinogenesis; 2005 May; 26(5):1000-7. PubMed ID: 15695235
[TBL] [Abstract][Full Text] [Related]
37. The induction of G2/M cell-cycle arrest and apoptosis by cucurbitacin E is associated with increased phosphorylation of eIF2alpha in leukemia cells.
Li Y; Wang R; Ma E; Deng Y; Wang X; Xiao J; Jing Y
Anticancer Drugs; 2010 Apr; 21(4):389-400. PubMed ID: 20110807
[TBL] [Abstract][Full Text] [Related]
38. Synthetic retinoids as inducers of apoptosis in ovarian carcinoma cell lines.
Holmes WF; Soprano DR; Soprano KJ
J Cell Physiol; 2004 Jun; 199(3):317-29. PubMed ID: 15095280
[TBL] [Abstract][Full Text] [Related]
39. Involvement of c-jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by cardiotoxin III (Naja naja atra) in K562 leukemia cells.
Yang SH; Chien CM; Chang LS; Lin SR
Toxicon; 2007 Jun; 49(7):966-74. PubMed ID: 17368702
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms of fenretinide-induced apoptosis of neuroblastoma cells.
Lovat PE; Corazzari M; Goranov B; Piacentini M; Redfern CP
Ann N Y Acad Sci; 2004 Dec; 1028():81-9. PubMed ID: 15650234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
